Cerebral Intraventricular Hemorrhage
"Cerebral Intraventricular Hemorrhage" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Bleeding within the CEREBRAL VENTRICLES. It is associated with intraventricular trauma, aneurysm, vascular malformations, hypertension and in VERY LOW BIRTH WEIGHT infants.
| Descriptor ID |
D000074042
|
| MeSH Number(s) |
C10.228.140.300.535.200.600 C14.907.253.573.200.600 C23.550.414.913.100.600
|
| Concept/Terms |
Cerebral Intraventricular Hemorrhage- Cerebral Intraventricular Hemorrhage
- Cerebral Intraventricular Hemorrhages
- Hemorrhage, Cerebral Intraventricular
- Intraventricular Hemorrhage, Cerebral
- Cerebral Intraventricular Haemorrhage
- Cerebral Intraventricular Haemorrhages
- Haemorrhage, Cerebral Intraventricular
- Intraventricular Haemorrhage, Cerebral
- Intraventricular Haemorrhages, Cerebral
|
Below are MeSH descriptors whose meaning is more general than "Cerebral Intraventricular Hemorrhage".
Below are MeSH descriptors whose meaning is more specific than "Cerebral Intraventricular Hemorrhage".
This graph shows the total number of publications written about "Cerebral Intraventricular Hemorrhage" by people in this website by year, and whether "Cerebral Intraventricular Hemorrhage" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cerebral Intraventricular Hemorrhage" by people in Profiles.
-
Primary Intraventricular Hemorrhage: Clinical Characteristics and Outcomes. J Stroke Cerebrovasc Dis. 2017 May; 26(5):995-999.
-
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017 02 11; 389(10069):603-611.